Checkpoint Therapeutics Inc

NASDAQ:CKPT

5.64

+0.03 (+0.54%)

7:42:34 PM EDT: $5.63 -0.01 (-0.18%)

Market Cap (Intraday)	52.75M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.04 Million
Adjusted EPS	-$1.33

See more estimates

10-Day MA	$5.42
50-Day MA	$5.31
200-Day MA	$9.88

See more pivots

Checkpoint Therapeutics Inc Stock, NASDAQ:CKPT

95 Sawyer Road, Suite 110, Waltham, Massachusetts 02453

United States of America

Phone: +1.781.652.4500

Number of Employees: 14

http://www.checkpointtx.com

Description

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.